Literature DB >> 17340641

Dynamic MR imaging of the gastroesophageal junction in healthy volunteers during bolus passage.

C Kulinna-Cosentini1, W Schima, E P Cosentini.   

Abstract

PURPOSE: To evaluate the feasibility of noninvasive dynamic fast magnetic resonance imaging (MRI) during swallowing in healthy volunteers, and to determine esophageal function at the gastroesophageal junction during swallowing.
MATERIALS AND METHODS: A total of 20 healthy volunteers underwent MRI while swallowing in the supine position. Dynamic gradient-echo (GRE) sequences (balanced fast field echo [B-FFE]) were employed in three planes on a 1.5T unit using a phased-array body coil. Buttermilk spiked with gadolinium (Gd) chelate (40:1) for bolus passage was used as an oral contrast agent. We evaluated visualization of esophageal bolus transit, bolus transit time (BTT), peristalsis, identification of the gastroesophageal junction, and reflux during the Valsalva maneuver.
RESULTS: The mean visible length of the esophagus was 16.2+/-5.3 cm in the sagittal view, and 13.8+/-4.9 cm in the coronal view. In the sagittal view the BTT was defined in 15 of 20 volunteers and was 7.6+/-1.4 seconds. The BTT in the coronal view was measured in seven of 20 volunteers and was 8+/-1.3 seconds on average. The axial view yielded higher scores (2.25) than the coronal (1.98) and sagittal (1.78) views for identification of the cardia and during the Valsalva maneuver. Bolus contrast was better displayed in the sagittal (2.2) view than in the coronal (2.08) or axial (1.73) planes. In six volunteers, gastroesophageal abnormalities, such as axial hernia, reflux, and nonperistaltic contractions, were identified. For statistical analysis we used the Friedman test and a one-way analysis of variance (ANOVA).
CONCLUSION: The results indicate that dynamic MR swallowing is a feasible and reproducible technique that warrants further studies in patients. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340641     DOI: 10.1002/jmri.20868

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Is there a role for dynamic swallowing MRI in the assessment of gastroesophageal reflux disease and oesophageal motility disorders?

Authors:  Christiane Kulinna-Cosentini; W Schima; J Lenglinger; M Riegler; C Kölblinger; A Ba-Ssalamah; G Bischof; M Weber; P Kleinhansl; E P Cosentini
Journal:  Eur Radiol       Date:  2011-09-06       Impact factor: 5.315

2.  MRI patterns of Nissen fundoplication: normal appearance and mechanisms of failure.

Authors:  Christiane Kulinna-Cosentini; Wolfgang Schima; Ahmed Ba-Ssalamah; Enrico P Cosentini
Journal:  Eur Radiol       Date:  2014-06-26       Impact factor: 5.315

Review 3.  New frontiers in esophageal radiology.

Authors:  Eric J Schmidlin; Ritu R Gill
Journal:  Ann Transl Med       Date:  2021-05

4.  Swallowing MRI-a reliable method for the evaluation of the postoperative gastroesophageal situs after Nissen fundoplication.

Authors:  Michael A Arnoldner; Ivan Kristo; Matthias Paireder; Enrico P Cosentini; Wolfgang Schima; Michael Weber; Sebastian F Schoppmann; Christiane Kulinna-Cosentini
Journal:  Eur Radiol       Date:  2018-11-12       Impact factor: 5.315

Review 5.  The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer.

Authors:  Anna Pellat; Anthony Dohan; Philippe Soyer; Julie Veziant; Romain Coriat; Maximilien Barret
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

6.  Comparison of investigation modalities for evaluation of esophageal peristaltic function.

Authors:  Takashi Kawai; Tetsuya Yamagishi
Journal:  J Clin Biochem Nutr       Date:  2008-05       Impact factor: 3.114

7.  Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing.

Authors:  Christiane Kulinna-Cosentini; Michael A Arnoldner; Wolfgang Schima; Ivan Kristo; Sebastian F Schoppmann; Michael Weber; Enrico P Cosentini
Journal:  Eur Radiol       Date:  2021-04-24       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.